- Home
- RVSN vs CLDI Comparison
RVSN vs CLDI Comparison
Compare RVSN & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVSN
- CLDI
- Stock Information
- Founded
- RVSN 2016
- CLDI 2014
- Country
- RVSN Israel
- CLDI United States
- Employees
- RVSN N/A
- CLDI N/A
- Industry
- RVSN
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RVSN
- CLDI Health Care
- Exchange
- RVSN Nasdaq
- CLDI Nasdaq
- Market Cap
- RVSN 20.5M
- CLDI 20.2M
- IPO Year
- RVSN 2022
- CLDI N/A
- Fundamental
- Price
- RVSN $0.40
- CLDI $5.36
- Analyst Decision
- RVSN
- CLDI
- Analyst Count
- RVSN 0
- CLDI 0
- Target Price
- RVSN N/A
- CLDI N/A
- AVG Volume (30 Days)
- RVSN 1.9M
- CLDI 992.7K
- Earning Date
- RVSN 08-29-2025
- CLDI 08-08-2025
- Dividend Yield
- RVSN N/A
- CLDI N/A
- EPS Growth
- RVSN N/A
- CLDI N/A
- EPS
- RVSN N/A
- CLDI N/A
- Revenue
- RVSN $1,300,000.00
- CLDI N/A
- Revenue This Year
- RVSN $1,861.54
- CLDI N/A
- Revenue Next Year
- RVSN N/A
- CLDI N/A
- P/E Ratio
- RVSN N/A
- CLDI N/A
- Revenue Growth
- RVSN 815.49
- CLDI N/A
- 52 Week Low
- RVSN $0.27
- CLDI $2.43
- 52 Week High
- RVSN $2.72
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- RVSN 50.63
- CLDI 41.12
- Support Level
- RVSN $0.35
- CLDI $4.75
- Resistance Level
- RVSN $0.44
- CLDI $7.32
- Average True Range (ATR)
- RVSN 0.06
- CLDI 1.06
- MACD
- RVSN -0.00
- CLDI -0.44
- Stochastic Oscillator
- RVSN 17.82
- CLDI 4.70
About RVSN Rail Vision Ltd.
Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.